AN EXCITING NEW PARTNERSHIP
1st January 2024
Happy New Year! Kicking off 2024, we’re thrilled to share the news of an exclusive collaboration between Hatsuno Sdn. Bhd. and Alliance Global FZ LLC (AGBL), a biomedical leader serving the Middle East, Africa and Asia.
This partnership is a milestone, aiming to make Hatsuno Kiseki postbiotic products accessible across the Gulf region, South Asia, Levant region, North, West and East Africa.
With a rich history of commitment to well-being through postbiotic innovations, Hatsuno is poised to enhance health outcomes with AGBL’s distribution network. With the trust our consumers have placed in us over the years, we are confident that this strategic alliance will further strengthen our dedication to delivering exceptional postbiotic solutions, reaching more individuals and contributing to a better quality of life.
Additionally, this partnership will see Hatsuno Kiseki products become the very first postbiotic products to be registered in these areas.
Key Highlights:
Enhanced Accessibility: AGBL will exclusively distribute Hatsuno’s postbiotic products, ensuring wider availability and access to innovative wellness solutions.
Shared Vision: Aligning in commitment to improving health outcomes, Hatsuno and AGBL will empower individuals with cutting-edge wellness solutions.
Efficient Distribution: Leveraging AGBL’s network, Hatsuno’s postbiotic products will seamlessly reach designated areas, promising a responsive approach to meeting wellness needs.
About AGBL:
Alliance Global FZ LLC (AGBL) stands as the largest biomedical gateway to emerging markets in the Middle East, Africa and Asia. Committed to advancing healthcare through innovative technologies, AGBL’s mission is to “Improve Lives through Science,” making transformative solutions accessible to researchers, clinicians, and diagnostic users in the emerging healthcare markets within the region.
